Endocrine Abstracts

There is increasing recognition that Thyroid Cancer represents a group of diseases with a broad spectrum of malignant behavior, ranging from the indolent papillary microcarcinoma carrying essentially no risk to the patients’ health of life; to Anaplastic Thyroid Cancer, the most aggressive human malignancy. The majority of our patients lie between these two extremes and their clinical management must increasingly be predicated on the threat that the disease represents to ...

There is increasing recognition that Thyroid Cancer represents a group of diseases with a broad spectrum of malignant behavior, ranging from the indolent papillary microcarcinoma carrying essentially no risk to the patients’ health of life; to Anaplastic Thyroid Cancer, the most aggressive human malignancy. The majority of our patients lie between these two extremes and their clinical management must increasingly be predicated on the threat that the disease represents to ...

The study aims were to characterize patients with papillary thyroid microcarcinoma (PTM) and to provide data on long-term outcome. About 900 patients with PTM (tumor size 1 cm or less) had treatment at our centre during 1945–2004. Follow-up extended to 54 years. Mean follow-up for 638 survivors was 13.5 years. Recurrence and mortality details were derived from a computerized database. Median tumour size was 7 mm. About 99% of tumors were grade 1; 98% were not locally inva...